Parkinson's disease is a progressive disorder that develops when the brain cells that produce dopamine (a chemical involved in movement) stop working or die. When this happens, symptoms like slowed ...

People with Parkinson's disease are more likely to develop certain types of dementia. Find out about the causes, symptoms and treatments. Parkinson’s disease is a brain disease that affects around 145 ...

Jan. 21, 2025 — The B vitamin mitigates manganese neurotoxicity, which produces symptoms that resemble Parkinson's disease. The vitamin improves dopamine production in the brain and offers ...

Dancing the Blues Away' Seen in Brain Imaging in People With Parkinson's Disease, New Study Finds Dec. 18, 2024 — Dancing lowers the depression associated with Parkinson's disease, and the ...

Get Instant Summarized Text (Gist) A key regulator for the GTPase function of the LRRK2 gene, linked to Parkinson's Disease, has been identified. This regulator, CalDAG-GEFI, can control the ...

The University of Tasmania will today launch a free Massive Open Online Course (MOOC) on Parkinson's Disease. The course — developed by the University's Wicking Dementia Research and Education ...

If they can inhibit this regulator, scientists can stop the overactivity of dardarin to slow the progression of Parkinson's Disease. Xiong completed this research using cell and mouse models.

Parkinson's disease (PD) and atypical Parkinsonian syndromes are progressive heterogeneous neurodegenerative diseases that share clinical characteristic of parkinsonism as a common feature, but are ...

Researchers have discovered how a cell surface protein called Aplp1 can play a role in spreading material responsible for Parkinson's disease from cell-to-cell in the brain. In a paper published last ...

Diagram of the regulation of LRRK2 GTPase function. Contributed image. Most other research has focused on understanding and targeting the kinase domain because it is an easier pharmaceutical target ...

The GLP-1 drug, exenatide, has no positive impact on the movement, symptoms or brain imaging of people with Parkinson's, finds a new study led by UCL researchers.